1型糖尿病胰岛自身抗体水平分布及其与遗传和临床特征的关系
该研究为前瞻性横断面研究,在1644例新诊断1型糖尿病患者中检测GADA、IA-2A和ZnT8A水平,发现GADA和IA-2A呈双峰分布,高低水平与不同年龄、性别、HLA型别及自身免疫病相关,并在449例独立队列中重复验证。
要点
- 新诊断1型糖尿病中GADA和IA-2A水平呈双峰分布,提示疾病异质性。
- 高GADA水平与较大年龄、女性、其他自身免疫病及HLA-DR3-DQ2相关。
- 高IA-2A水平与较小年龄、HLA-DR4-DQ8及ZnT8A阳性相关。
核心结论
- 胰岛自身抗体水平在1型糖尿病诊断时提供超越阳性与否的额外信息。
- GADA和IA-2A水平的双峰分布突显了1型糖尿病异质性的新方面。
- 这可能对1型糖尿病的预测、治疗和发病机制有启示。
研究设计与样本
- 前瞻性横断面研究,纳入1644例新诊断1型糖尿病患者,用放射结合法检测GADA、IA-2A和ZnT8A。
- 在449例1型糖尿病独立队列中用酶联免疫吸附法检测自身抗体进行重复验证。
主要发现
- 高GADA水平组与低水平组相比:诊断年龄中位数27岁 vs 19岁(P=9×10⁻¹⁷),女性52% vs 37%(P=1×10⁻⁸),其他自身免疫病13% vs 6%(P=3×10⁻⁶),HLA-DR3-DQ2 58% vs 51%(P=.006)。
- 高IA-2A水平组与低水平组相比:诊断年龄中位数17岁 vs 23岁(P=3×10⁻⁷),HLA-DR4-DQ8 66% vs 50%(P=1×10⁻⁶),ZnT8A阳性77% vs 52%(P=1×10⁻¹⁵)。
- 在449例独立队列中重复了上述发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The importance of the autoantibody level at diagnosis of type 1 diabetes (T1D) is not clear. OBJECTIVE: We aimed to assess the association of glutamate decarboxylase (GADA), islet antigen-2 (IA-2A), and zinc transporter 8 (ZnT8A) autoantibody levels with clinical and genetic characteristics at diagnosis of T1D. METHODS: We conducted a prospective, cross-sectional study. GADA, IA-2A, and ZnT8A were measured in 1644 individuals with T1D at diagnosis using radiobinding assays. Associations between autoantibody levels and the clinical and genetic characteristics for individuals were assessed in those positive for these autoantibodies. We performed replication in an independent cohort of 449 people with T1D. RESULTS: GADA and IA-2A levels exhibited a bimodal distribution at diagnosis. High GADA level was associated with older age at diagnosis (median 27 years vs 19 years, P = 9 × 10-17), female sex (52% vs 37%, P = 1 × 10-8), other autoimmune diseases (13% vs 6%, P = 3 × 10-6), and HLA-DR3-DQ2 (58% vs 51%, P = .006). High IA-2A level was associated with younger age of diagnosis (median 17 years vs 23 years, P = 3 × 10-7), HLA-DR4-DQ8 (66% vs 50%, P = 1 × 10-6), and ZnT8A positivity (77% vs 52%, P = 1 × 10-15). We replicated our findings in an independent cohort of 449 people with T1D where autoantibodies were measured using enzyme-linked immunosorbent assays. CONCLUSION: Islet autoantibody levels provide additional information over positivity in T1D at diagnosis. Bimodality of GADA and IA-2A autoantibody levels highlights the novel aspect of heterogeneity of T1D. This may have implications for T1D prediction, treatment, and pathogenesis.
引用
- Grace SL, Bowden J, Walkey HC, et al. Islet Autoantibody Level Distribution in Type 1 Diabetes and Their Association With Genetic and Clinical Characteristics. J Clin Endocrinol Metab. 2022. PMID: 36073000. doi:10.1210/clinem/dgac507
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。